Selected research
Industry Research
Pharmaceutical Analysis Services Industry Research Report 2026
Market perspective
The global Pharmaceutical Analysis Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharmaceutical Analysis Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmaceutical Analysis Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmaceutical Analysis Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmaceutical Analysis Services include Eurofins, WuXi AppTec, Pace Analytical Services, Catalent, LabCorp (Covance), PPD, Element (Exova), ALS Pharmaceutical and Intertek Group, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharmaceutical Analysis Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmaceutical Analysis Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical Analysis Services Market by Company
Eurofins
WuXi AppTec
Pace Analytical Services
Catalent
LabCorp (Covance)
PPD
Element (Exova)
ALS Pharmaceutical
Intertek Group
SGS
Boston Analytical
DYNALABS
ADPEN Laboratories
ARL Bio Pharma
West Pharmaceutical
Microbac
Element (Analytical Lab Group)
Piramal Pharma Solutions
CTI
Weipu
PONY Medicine
Pharmaceutical Analysis Services Segment by Type
Raw Material Analysis
Microbiological Analysis
Drug Packaging Material Analysis
Biological Analysis and Testing
Other
Pharmaceutical Analysis Services Segment by Application
CRO
CMO and CDMO
Finished Drugs and Environment
Pharmaceutical Analysis Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Analysis Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Analysis Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Analysis Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmaceutical Analysis Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Raw Material Analysis
- Microbiological Analysis
- Drug Packaging Material Analysis
- Biological Analysis and Testing
- Other
Applications
- CRO
- CMO and CDMO
- Finished Drugs and Environment
Companies covered
- Eurofins
- WuXi AppTec
- Pace Analytical Services
- Catalent
- LabCorp (Covance)
- PPD
- Element (Exova)
- ALS Pharmaceutical
- Intertek Group
- SGS
- Boston Analytical
- DYNALABS
- ADPEN Laboratories
- ARL Bio Pharma
- West Pharmaceutical
- Microbac
- Element (Analytical Lab Group)
- Piramal Pharma Solutions
- CTI
- Weipu
- PONY Medicine
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmaceutical Analysis Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Raw Material Analysis
- 2.2.3 Microbiological Analysis
- 2.2.4 Drug Packaging Material Analysis
- 2.2.5 Biological Analysis and Testing
- 2.2.6 Other
- 2.3 Pharmaceutical Analysis Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 CRO
- 2.3.3 CMO and CDMO
- 2.3.4 Finished Drugs and Environment
- 2.4 Assumptions and Limitations
3 Pharmaceutical Analysis Services Breakdown Data by Type
- 3.1 Global Pharmaceutical Analysis Services Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmaceutical Analysis Services Forecasted Market Size by Type (2027-2032)
4 Pharmaceutical Analysis Services Breakdown Data by Application
- 4.1 Global Pharmaceutical Analysis Services Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmaceutical Analysis Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmaceutical Analysis Services Market Perspective (2021-2032)
- 5.2 Global Pharmaceutical Analysis Services Growth Trends by Region
- 5.2.1 Global Pharmaceutical Analysis Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmaceutical Analysis Services Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmaceutical Analysis Services Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmaceutical Analysis Services Market Dynamics
- 5.3.1 Pharmaceutical Analysis Services Industry Trends
- 5.3.2 Pharmaceutical Analysis Services Market Drivers
- 5.3.3 Pharmaceutical Analysis Services Market Challenges
- 5.3.4 Pharmaceutical Analysis Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmaceutical Analysis Services Players by Revenue
- 6.1.1 Global Top Pharmaceutical Analysis Services Players by Revenue (2021-2026)
- 6.1.2 Global Pharmaceutical Analysis Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmaceutical Analysis Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmaceutical Analysis Services Head Office and Area Served
- 6.4 Global Pharmaceutical Analysis Services Players, Product Type & Application
- 6.5 Global Pharmaceutical Analysis Services Manufacturers Established Date
- 6.6 Global Pharmaceutical Analysis Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmaceutical Analysis Services Market Size (2021-2032)
- 7.2 North America Pharmaceutical Analysis Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmaceutical Analysis Services Market Size by Country (2021-2026)
- 7.4 North America Pharmaceutical Analysis Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmaceutical Analysis Services Market Size (2021-2032)
- 8.2 Europe Pharmaceutical Analysis Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmaceutical Analysis Services Market Size by Country (2021-2026)
- 8.4 Europe Pharmaceutical Analysis Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical Analysis Services Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmaceutical Analysis Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmaceutical Analysis Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmaceutical Analysis Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmaceutical Analysis Services Market Size (2021-2032)
- 10.2 South America Pharmaceutical Analysis Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmaceutical Analysis Services Market Size by Country (2021-2026)
- 10.4 South America Pharmaceutical Analysis Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical Analysis Services Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmaceutical Analysis Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmaceutical Analysis Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmaceutical Analysis Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eurofins
- 12.1.1 Eurofins Company Information
- 12.1.2 Eurofins Business Overview
- 12.1.3 Eurofins Revenue in Pharmaceutical Analysis Services Business (2021-2026)
- 12.1.4 Eurofins Pharmaceutical Analysis Services Product Portfolio
- 12.1.5 Eurofins Recent Developments
- 12.2 WuXi AppTec
- 12.2.1 WuXi AppTec Company Information
- 12.2.2 WuXi AppTec Business Overview
- 12.2.3 WuXi AppTec Revenue in Pharmaceutical Analysis Services Business (2021-2026)
- 12.2.4 WuXi AppTec Pharmaceutical Analysis Services Product Portfolio
- 12.2.5 WuXi AppTec Recent Developments
- 12.3 Pace Analytical Services
- 12.3.1 Pace Analytical Services Company Information
- 12.3.2 Pace Analytical Services Business Overview
- 12.3.3 Pace Analytical Services Revenue in Pharmaceutical Analysis Services Business (2021-2026)
- 12.3.4 Pace Analytical Services Pharmaceutical Analysis Services Product Portfolio
- 12.3.5 Pace Analytical Services Recent Developments
- 12.4 Catalent
- 12.4.1 Catalent Company Information
- 12.4.2 Catalent Business Overview
- 12.4.3 Catalent Revenue in Pharmaceutical Analysis Services Business (2021-2026)
- 12.4.4 Catalent Pharmaceutical Analysis Services Product Portfolio
- 12.4.5 Catalent Recent Developments
- 12.5 LabCorp (Covance)
- 12.5.1 LabCorp (Covance) Company Information
- 12.5.2 LabCorp (Covance) Business Overview
- 12.5.3 LabCorp (Covance) Revenue in Pharmaceutical Analysis Services Business (2021-2026)
- 12.5.4 LabCorp (Covance) Pharmaceutical Analysis Services Product Portfolio
- 12.5.5 LabCorp (Covance) Recent Developments
- 12.6 PPD
- 12.6.1 PPD Company Information
- 12.6.2 PPD Business Overview
- 12.6.3 PPD Revenue in Pharmaceutical Analysis Services Business (2021-2026)
- 12.6.4 PPD Pharmaceutical Analysis Services Product Portfolio
- 12.6.5 PPD Recent Developments
- 12.7 Element (Exova)
- 12.7.1 Element (Exova) Company Information
- 12.7.2 Element (Exova) Business Overview
- 12.7.3 Element (Exova) Revenue in Pharmaceutical Analysis Services Business (2021-2026)
- 12.7.4 Element (Exova) Pharmaceutical Analysis Services Product Portfolio
- 12.7.5 Element (Exova) Recent Developments
- 12.8 ALS Pharmaceutical
- 12.8.1 ALS Pharmaceutical Company Information
- 12.8.2 ALS Pharmaceutical Business Overview
- 12.8.3 ALS Pharmaceutical Revenue in Pharmaceutical Analysis Services Business (2021-2026)
- 12.8.4 ALS Pharmaceutical Pharmaceutical Analysis Services Product Portfolio
- 12.8.5 ALS Pharmaceutical Recent Developments
- 12.9 Intertek Group
- 12.9.1 Intertek Group Company Information
- 12.9.2 Intertek Group Business Overview
- 12.9.3 Intertek Group Revenue in Pharmaceutical Analysis Services Business (2021-2026)
- 12.9.4 Intertek Group Pharmaceutical Analysis Services Product Portfolio
- 12.9.5 Intertek Group Recent Developments
- 12.10 SGS
- 12.10.1 SGS Company Information
- 12.10.2 SGS Business Overview
- 12.10.3 SGS Revenue in Pharmaceutical Analysis Services Business (2021-2026)
- 12.10.4 SGS Pharmaceutical Analysis Services Product Portfolio
- 12.10.5 SGS Recent Developments
- 12.11 Boston Analytical
- 12.11.1 Boston Analytical Company Information
- 12.11.2 Boston Analytical Business Overview
- 12.11.3 Boston Analytical Revenue in Pharmaceutical Analysis Services Business (2021-2026)
- 12.11.4 Boston Analytical Pharmaceutical Analysis Services Product Portfolio
- 12.11.5 Boston Analytical Recent Developments
- 12.12 DYNALABS
- 12.12.1 DYNALABS Company Information
- 12.12.2 DYNALABS Business Overview
- 12.12.3 DYNALABS Revenue in Pharmaceutical Analysis Services Business (2021-2026)
- 12.12.4 DYNALABS Pharmaceutical Analysis Services Product Portfolio
- 12.12.5 DYNALABS Recent Developments
- 12.13 ADPEN Laboratories
- 12.13.1 ADPEN Laboratories Company Information
- 12.13.2 ADPEN Laboratories Business Overview
- 12.13.3 ADPEN Laboratories Revenue in Pharmaceutical Analysis Services Business (2021-2026)
- 12.13.4 ADPEN Laboratories Pharmaceutical Analysis Services Product Portfolio
- 12.13.5 ADPEN Laboratories Recent Developments
- 12.14 ARL Bio Pharma
- 12.14.1 ARL Bio Pharma Company Information
- 12.14.2 ARL Bio Pharma Business Overview
- 12.14.3 ARL Bio Pharma Revenue in Pharmaceutical Analysis Services Business (2021-2026)
- 12.14.4 ARL Bio Pharma Pharmaceutical Analysis Services Product Portfolio
- 12.14.5 ARL Bio Pharma Recent Developments
- 12.15 West Pharmaceutical
- 12.15.1 West Pharmaceutical Company Information
- 12.15.2 West Pharmaceutical Business Overview
- 12.15.3 West Pharmaceutical Revenue in Pharmaceutical Analysis Services Business (2021-2026)
- 12.15.4 West Pharmaceutical Pharmaceutical Analysis Services Product Portfolio
- 12.15.5 West Pharmaceutical Recent Developments
- 12.16 Microbac
- 12.16.1 Microbac Company Information
- 12.16.2 Microbac Business Overview
- 12.16.3 Microbac Revenue in Pharmaceutical Analysis Services Business (2021-2026)
- 12.16.4 Microbac Pharmaceutical Analysis Services Product Portfolio
- 12.16.5 Microbac Recent Developments
- 12.17 Element (Analytical Lab Group)
- 12.17.1 Element (Analytical Lab Group) Company Information
- 12.17.2 Element (Analytical Lab Group) Business Overview
- 12.17.3 Element (Analytical Lab Group) Revenue in Pharmaceutical Analysis Services Business (2021-2026)
- 12.17.4 Element (Analytical Lab Group) Pharmaceutical Analysis Services Product Portfolio
- 12.17.5 Element (Analytical Lab Group) Recent Developments
- 12.18 Piramal Pharma Solutions
- 12.18.1 Piramal Pharma Solutions Company Information
- 12.18.2 Piramal Pharma Solutions Business Overview
- 12.18.3 Piramal Pharma Solutions Revenue in Pharmaceutical Analysis Services Business (2021-2026)
- 12.18.4 Piramal Pharma Solutions Pharmaceutical Analysis Services Product Portfolio
- 12.18.5 Piramal Pharma Solutions Recent Developments
- 12.19 CTI
- 12.19.1 CTI Company Information
- 12.19.2 CTI Business Overview
- 12.19.3 CTI Revenue in Pharmaceutical Analysis Services Business (2021-2026)
- 12.19.4 CTI Pharmaceutical Analysis Services Product Portfolio
- 12.19.5 CTI Recent Developments
- 12.20 Weipu
- 12.20.1 Weipu Company Information
- 12.20.2 Weipu Business Overview
- 12.20.3 Weipu Revenue in Pharmaceutical Analysis Services Business (2021-2026)
- 12.20.4 Weipu Pharmaceutical Analysis Services Product Portfolio
- 12.20.5 Weipu Recent Developments
- 12.21 PONY Medicine
- 12.21.1 PONY Medicine Company Information
- 12.21.2 PONY Medicine Business Overview
- 12.21.3 PONY Medicine Revenue in Pharmaceutical Analysis Services Business (2021-2026)
- 12.21.4 PONY Medicine Pharmaceutical Analysis Services Product Portfolio
- 12.21.5 PONY Medicine Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst